Direct Estimation of Sensitivity of Rapid Diagnostic Test for Active Case Detection in a High-Transmission Community Setting
Overview
Authors
Affiliations
Community-based active case detection of malaria parasites with conventional rapid diagnostic tests (cRDTs) is a strategy used most commonly in low-transmission settings. We estimated the sensitivity of this approach in a high-transmission setting in Western Kenya. We tested 3,547 members of 912 households identified in 2013-2014 by index children with (case) and without (control) cRDT-positive malaria. All were tested for with both a cRDT targeting histidine-rich protein 2 and with an ultrasensitive real-time polymerase chain reaction (PCR). We computed cRDT sensitivity against PCR as the referent, compared prevalence between participant types, and estimated cRDT detectability as a function of PCR-estimated parasite density. Parasite prevalence was 22.9% by cRDTs and 61.5% by PCR. Compared with children aged < 5 years or adults aged > 15 years, geometric mean parasite densities (95% CI) were highest in school-age children aged 5-15 years (8.4 p/uL; 6.6-10.6). The overall sensitivity of cRDT was 36%; among asymptomatic household members, cRDT sensitivity was 25.5% and lowest in adults aged > 15 years (15.8%). When modeled as a function of parasite density, relative to school-age children, the probability of cRDT positivity was reduced in both children aged < 5 years (odds ratio [OR] 0.48; 95% CI: 0.34-0.69) and in adults aged > 15 years (OR: 0.35; 95% CI: 0.27-0.47). An HRP2-detecting cRDT had poor sensitivity for active case detection in asymptomatic community members, and sensitivity was lowest in highly prevalent low-density infections and in adults. Future studies can model the incremental effects of high-sensitivity rapid diagnostic tests and the impacts on transmission.
Leuba S, Westreich D, Bose C, Olshan A, Taylor S, Tshefu A PLoS One. 2024; 19(12):e0310339.
PMID: 39705264 PMC: 11661578. DOI: 10.1371/journal.pone.0310339.
Lapp Z, Freedman E, Huang K, Markwalter C, Obala A, Prudhomme-OMeara W PLOS Glob Public Health. 2024; 4(5):e0002361.
PMID: 38814915 PMC: 11139333. DOI: 10.1371/journal.pgph.0002361.
Zeno E, Obala A, Pence B, Freedman E, Mangeni J, Lin J J Infect Dis. 2023; 229(4):969-978.
PMID: 37713614 PMC: 11011184. DOI: 10.1093/infdis/jiad398.
Markwalter C, Petersen J, Zeno E, Sumner K, Freedman E, Mangeni J PLoS Pathog. 2023; 19(6):e1011442.
PMID: 37307293 PMC: 10289385. DOI: 10.1371/journal.ppat.1011442.
Mwangonela Z, Ye Y, Rachel Q, Msuya H, Mwamlima T, Mswata S Bull Natl Res Cent. 2023; 47(1):17.
PMID: 36776799 PMC: 9904258. DOI: 10.1186/s42269-023-00992-4.